Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
1.
Public Health ; 173: 5-8, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31207425

RESUMO

OBJECTIVE: The objective of this study was to explore factors influencing patients with hypertension to participating in a hypertension self-management education (HSME) programme and challenges of sustaining the learnt self-care practices. STUDY DESIGN: This was a qualitative study with focus group discussions. METHODS: Focus group discussions using a semistructured moderator guide were conducted among participants who had attended the HSME programme. Data were audio recorded, transcribed verbatim and analysed using a thematic analysis approach. RESULTS: Three focus groups involving 19 participants were conducted. Four major themes emerged from the data collected. Most participants enjoyed the group-based HSME sessions because sharing experiences with those having similar health problems can reduce their sense of isolation. However, the participants highlighted the difficulty in sustaining self-care practices in the presence of friends and family influences. CONCLUSION: A number of patient-, family- and community-level motivators and barriers to patients' hypertension self-management have been identified. Efforts to tailor behavioural interventions to sustain daily self-care activities during social and cultural events are imperative.


Assuntos
Educação em Saúde , Conhecimentos, Atitudes e Prática em Saúde , Hipertensão/terapia , Motivação , Educação de Pacientes como Assunto , Autocuidado/psicologia , Autogestão/psicologia , Idoso , Feminino , Grupos Focais , Humanos , Hipertensão/psicologia , Masculino , Pessoa de Meia-Idade , Pesquisa Qualitativa
2.
Value Health Reg Issues ; 15: 161-168, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29730249

RESUMO

BACKGROUND: Low rate of adherence was found strongly associated with patients' beliefs across the studies about chronic diseases with hypertension. A crucial move is needed to bridge the gap between appropriate assessment tools and local hypertensive patients' medication adherence. OBJECTIVE: To produce a translated version in Malay language of Beliefs about Medicines Questionnaire (BMQ) that was "conceptually equivalent" to the original English version for use in local clinical practice and research. METHODS: The forward translation process was conducted by two independent professional translators and back translation was done by two other independent translators. A reliability analysis was conducted on 238 conveniently selected hypertensive patients. Intraclass correlation coefficient (ICC) was used to assess test-retest reliability for the randomly selected 40 patients in a period of 2 weeks. Discriminant validity was tested through Necessity-Concerns differential, BMQ subscales, and other parameters. RESULTS: The overall Cronbach alpha for the internal consistency was good (0.860). The subscales of the BMQ demonstrated adequate internal consistency, with Cronbach alpha value of 0.759 for Specific-Necessity, 0.762 for Specific Concern, 0.624 for General-Overuse, and 0.756 for General-Harm. The ICC was excellent (0.922). Discriminant validity revealed that BMQ Specific-Necessity score was significantly inversely correlated with the systolic blood pressure level. Systolic and diastolic blood pressure levels (P = 0.038; P = 0.05) were reported to be significantly correlated with the Necessity-Concerns differential, with Necessity score equal or exceeding Concerns score. CONCLUSIONS: The Malay-translated version of BMQ is a reliable and valid tool to assess patient belief about medication, especially medication adherence among the hypertensive patients in Malaysia.


Assuntos
Competência Cultural , Linguística , Adesão à Medicação/estatística & dados numéricos , Inquéritos e Questionários/normas , Traduções , Doença Crônica/tratamento farmacológico , Estudos Transversais , Feminino , Humanos , Hipertensão/tratamento farmacológico , Malásia , Masculino , Pessoa de Meia-Idade , Psicometria , Reprodutibilidade dos Testes
3.
Eur J Clin Microbiol Infect Dis ; 37(3): 537-544, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29185089

RESUMO

Micafungin was shown to be as efficacious as caspofungin in treating patients with candidaemia and invasive candidiasis (IC). However, it remains unknown if micafungin or caspofungin is a cost-effective definitive therapy for candidaemia and IC in Turkey. The present study aimed to determine the economic impact of using micafungin versus caspofungin for treatment of candidaemia and IC in the Turkish setting. A decision analytic model was constructed and was populated with data (i.e. transition probabilities, duration of initial antifungal treatment, reasons for treatment failure, percentage of patients who stepped down to oral fluconazole, and duration on oral fluconazole) obtained from a published randomised clinical trial. Cost inputs were derived from the latest Turkish resources while data that were not readily available in the literature were estimated by expert panels. One-way sensitivity analyses, threshold analyses, scenario analyses and probabilistic sensitivity analyses were conducted. Caspofungin (€2693) incurred a lower total cost than micafungin (€4422), with a net cost saving of €1729 per treated patient. Drug acquisition cost was the main cost driver for both study arms. The model outcome was robust over wide variations (of ±100.0% from the base case value) for all input parameters except for micafungin drug cost and the duration of initial treatment with micafungin. Caspofungin appears to be a cost-saving option in treating candidaemia and IC from the Turkish hospital perspective.


Assuntos
Antifúngicos/economia , Candidemia/tratamento farmacológico , Equinocandinas/economia , Lipopeptídeos/economia , Modelos Econômicos , Antifúngicos/uso terapêutico , Candidemia/economia , Candidemia/epidemiologia , Candidíase Invasiva/tratamento farmacológico , Candidíase Invasiva/economia , Candidíase Invasiva/epidemiologia , Caspofungina , Análise Custo-Benefício , Bases de Dados Factuais , Equinocandinas/uso terapêutico , Humanos , Lipopeptídeos/uso terapêutico , Micafungina , Resultado do Tratamento , Turquia/epidemiologia
4.
Eye (Lond) ; 29(9): 1162-6, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26043705

RESUMO

PURPOSE: To review the histopathological diagnoses, visual outcome, and complication rate of orbital biopsy in a UK tertiary referral centre. METHODS: This was a retrospective, clinical-pathological, interventional, consecutive case series. All orbital biopsies performed between July 2004 and June 2014 in Newcastle Eye Centre (Newcastle upon Tyne, UK) were included in this study. All relevant data collected from the local electronic database and medical records were analysed. RESULTS: A total of 166 orbital biopsies were identified during the study period: 86 patients (53.1%) were female and the mean age was 53.7 ± 19.7 years. Of all the cases, orbital biopsies were performed unilaterally in 158 (97.5%) patients and bilaterally in 4 (2.5%) patients. The mean follow-up period was 2.2 ± 2.3 years. The two most common histopathological diagnoses were non-specific inflammatory disease (62, 38.3%) and lymphoproliferative disease (40, 24.7%). None of the patients experienced ≥ 2-Snellen line visual loss. There were 7 (4.2%) postoperative complications noted: 1 (0.6%) orbital haemorrhage with no loss of vision, 4 (2.4%) diplopia, 1 (0.6%) short-term symblepharon, and 1 (0.6%) conjunctival granuloma. Postoperative diplopia was associated with lateral orbitotomy (P = 0.044) and excisional biopsy (P = 0.015). CONCLUSIONS: Orbital biopsy serves as a safe diagnostic tool in managing orbital diseases. Patient should be made aware of the risk of postoperative diplopia. Our data provides useful guidance to clinicians when counselling patients for orbital biopsy.


Assuntos
Doenças Orbitárias/patologia , Adulto , Idoso , Biópsia/métodos , Diplopia/etiologia , Inglaterra , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Orbitárias/fisiopatologia , Complicações Pós-Operatórias/etiologia , Estudos Retrospectivos , Acuidade Visual/fisiologia , Adulto Jovem
5.
Intern Med J ; 43(6): 668-77, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23461421

RESUMO

BACKGROUND: Micafungin demonstrated non-inferiority to caspofungin as definitive therapy for candidaemia and invasive candidiasis (IC) in a major randomised clinical trial. AIM: The aim of this study was to investigate if micafungin is a cost-saving option compared with caspofungin for treating candidaemia and IC. METHODS: A decision analytical model was constructed to capture downstream consequences of using either agent as initial therapy for candidaemia and IC. The main outcomes were treatment success and treatment failure (i.e. death, mycological persistence, emergent infection, clinical failure but microbiological success). Outcome probabilities and treatment pathways were derived from the literature. Cost inputs were from the latest Australian resources, and resource use was estimated by expert panel. The analysis was from the Australian hospital perspective. Sensitivity analyses using Monte Carlo simulation were conducted. RESULTS: Micafungin (AU$52 816) was associated with a lower total cost than caspofungin (AU$52 976), with a net cost-saving of $160 per patient. This was primarily due to the lower cost associated with alternative antifungal treatment in the micafungin arm. Hospitalisation was the main cost-driver for both arms. The model outcome was most sensitive to the proportion of treatment success in the micafungin arm. Uncertainty analysis demonstrated that micafungin had a 58% chance of being cost-saving compared with caspofungin. CONCLUSIONS: Micafungin was cost-equivalent to caspofungin in treating candidaemia and IC, with variation in drug acquisition cost the critical factor.


Assuntos
Antifúngicos/economia , Candidemia/tratamento farmacológico , Candidemia/economia , Equinocandinas/economia , Lipopeptídeos/economia , Modelos Econômicos , Antifúngicos/uso terapêutico , Candidíase Invasiva/tratamento farmacológico , Candidíase Invasiva/economia , Caspofungina , Análise Custo-Benefício/economia , Equinocandinas/uso terapêutico , Humanos , Lipopeptídeos/uso terapêutico , Micafungina , Resultado do Tratamento
6.
Transpl Infect Dis ; 15(4): 344-53, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23527908

RESUMO

BACKGROUND: Invasive fungal infection (IFI) is associated with high mortality in lung transplant (LTx) recipients. Data for voriconazole use in preemptive treatment remain scant. METHOD: A single-center, retrospective cohort study was conducted to investigate the efficacy and safety of voriconazole preemptive treatment for post-LTx colonization. RESULTS: We reviewed 62 adult LTx patients, who received their first course of voriconazole prophylaxis (i.e., as preemptive treatment) between July 2003 and June 2010. Outcomes were determined at 6 and 12 months after commencing therapy. Aspergillus fumigatus (75.8%) was the most common colonizing isolate. Median duration of voriconazole prophylaxis was 85 days. At 6 months, 1 LTx patient (1.6%) had IFI, 47 (75.8%) cleared their colonizing isolate, 3 (4.8%) had persistent colonization, 7 (11.3%) had recurrent colonization, 1 (1.6%) had new colonization, 2 (3.2%) had aspergilloma, and 1 (1.6%) was clinically unstable with no culture results. Sixteen (25.8%) had died by 12 months. Ten (16.1%) had likely drug-related hepatotoxicity. LTx patients with diabetes mellitus within 30 days before commencing prophylaxis were at higher risk of recurrent Aspergillus colonization at 6 months (P = 0.030). Chronic rejection within 30 days before prophylaxis was associated with 12-month mortality (P = 0.007). CONCLUSIONS: Voriconazole preemptive treatment resulted in low incidence of IFI and IFI-related mortality.


Assuntos
Antifúngicos/uso terapêutico , Transplante de Pulmão/efeitos adversos , Micoses/epidemiologia , Micoses/mortalidade , Pirimidinas/uso terapêutico , Triazóis/uso terapêutico , Adolescente , Adulto , Idoso , Aspergillus fumigatus/efeitos dos fármacos , Aspergillus fumigatus/isolamento & purificação , Estudos de Coortes , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Micoses/microbiologia , Micoses/prevenção & controle , Estudos Retrospectivos , Resultado do Tratamento , Voriconazol , Adulto Jovem
7.
Singapore Med J ; 53(2): e24-7, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22337196

RESUMO

Rhinoscleroma is a chronic, slowly progressive, inflammatory disease of the upper respiratory tract. It is associated with Klebsiella rhinoscleromatis infection. We present the clinical and pathological features of four patients diagnosed with rhinoscleroma at the National Skin Centre, Singapore between 1997 and 2010. All four patients presented with only cutaneous involvement, and the diagnosis was clinched via histological examination. The patients were treated with a combination of antibiotics. Two patients who were on follow-up at the time of this writing responded positively to the antibiotic treatment, while two were lost to follow-up. Rhinoscleroma is a diagnostic challenge, as it is an uncommon disease in Singapore and Malaysia. We highlight this condition to raise awareness of the disease in order to aid in early diagnosis of patients. Without treatment, this condition can result in significant complications, including involvement of the lower airways. Early diagnosis and appropriate treatment help to reduce morbidity.


Assuntos
Rinoscleroma/patologia , Adulto , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Ciprofloxacina/administração & dosagem , Ciprofloxacina/uso terapêutico , Doxiciclina/administração & dosagem , Doxiciclina/uso terapêutico , Quimioterapia Combinada , Feminino , Humanos , Pessoa de Meia-Idade , Nariz/patologia , Rinoscleroma/diagnóstico , Rinoscleroma/epidemiologia , Singapura/epidemiologia
8.
Am J Transplant ; 11(2): 361-6, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21272239

RESUMO

While variations in antifungal prophylaxis have been previously reported in lung transplant (LTx) recipients, recent clinical practice is unknown. Our aim was to determine current antifungal prophylactic practice in LTx centers world-wide. One nominated LTx clinician from each active center was invited by e-mail to participate in a web-based survey between September 2009 and January 2010. Fifty-seven percent (58/102) responded. The majority of responses were from medical directors of LTx centers (72.4%), and from the United States (44.8%). Within the first 6 months post-LTx, most centers (58.6%) employed universal prophylaxis, with 97.1% targeting Aspergillus species. Voriconazole alone, and in combination with inhaled amphotericin B (AmB), were the preferred first-line agents. Intolerance to side effects of voriconazole (69.2%) was the main reason for switching to alternatives. Beyond 6 months post-LTx, most (51.8%) did not employ antifungal prophylaxis. Fifteen centers (26.0%) conducted routine antifungal therapeutic drug monitoring during prophylactic period. There are differences in strategies employed between U.S. and European centers. Most respondents indicated a need for antifungal prophylactic guidelines. In comparison to earlier findings, there was a major shift toward prophylaxis with voriconazole and an increased use of echinocandins, posaconazole and inhaled lipid formulation AmB.


Assuntos
Antifúngicos/farmacologia , Transplante de Pulmão/métodos , Micoses/prevenção & controle , Adulto , Coleta de Dados , Europa (Continente) , Humanos , Transplante de Pulmão/efeitos adversos , Micoses/etiologia , Fatores de Tempo , Estados Unidos
9.
Osteoarthritis Cartilage ; 18(9): 1192-202, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20510383

RESUMO

OBJECTIVE: To study the effects of oral glucosamine sulfate on the development of osteoarthritis (OA) and to examine concomitant changes in the nociceptive behavior of rats. METHODS: OA was induced in Wistar rats by anterior cruciate ligament transection (ACLT) of the right knee; the left knee was untreated. The OA+glucosamine group received oral glucosamine sulfate (250 mg/kg/day) in a 2-g wafer once a day for 10 consecutive weeks starting at week 5 after ACLT. The OA group was treated as above with 2-g wafers (placebo). The control group of naïve rats received 2-g wafers only. The glucosamine alone group comprised naïve rats receiving glucosamine sulfate only. Nociceptive behavior (mechanical allodynia and weight-bearing distribution of hind paws) during OA development was analyzed pre- and 3, 6, 9, 12, 15, and 18 weeks post-ACLT. Macroscopic and histologic studies were then performed on the cartilage and synovia. Immunohistochemical analysis was performed to examine the effect of glucosamine on expression of mitogen-activated protein kinases (MAPKs) in the articular cartilage chondrocytes. RESULTS: OA rats receiving glucosamine showed a significantly lower degree of cartilage degeneration than the rats receiving placebo. Glucosamine treatment also suppressed synovitis. Mechanical allodynia and weight-bearing distribution studies showed significant improvement in the OA+glucosamine group as compared to the OA group. Moreover, glucosamine attenuated p38 and c-Jun N-terminal kinase (JNK) but increased extracellular signal-regulated kinase 1/2 (ERK) expression in OA-affected cartilage. CONCLUSION: Our results indicate that treatment with oral glucosamine sulfate in a rat OA model (1) attenuates the development of OA, (2) concomitantly reduces nociception, and (3) modulates chondrocyte metabolism, possibly through inhibition of cell p38 and JNK and increase of ERK expression.


Assuntos
Cartilagem Articular/patologia , Condrócitos/efeitos dos fármacos , Condrócitos/enzimologia , Glucosamina/farmacologia , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Osteoartrite do Joelho/patologia , Administração Oral , Animais , Comportamento Animal/efeitos dos fármacos , Cartilagem Articular/efeitos dos fármacos , Modelos Animais de Doenças , Lateralidade Funcional/efeitos dos fármacos , Imuno-Histoquímica , Articulação do Joelho/patologia , Nociceptores/efeitos dos fármacos , Osteoartrite do Joelho/tratamento farmacológico , Medição da Dor/métodos , Ratos , Ratos Wistar , Membrana Sinovial/patologia , Suporte de Carga/fisiologia
10.
Clin Exp Dermatol ; 35(3): 300-4, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19663842

RESUMO

BACKGROUND: Pityriasis rosea (PR) is a common cutaneous papulosquamous disorder affecting young adults. Previous studies have suggested possibilities of a viral aetiology and the involvement of cell-mediated immunity, but these remain unproven to date. AIM: To elucidate the possible pathomechanisms in PR by characterizing the inflammatory cellular infiltrate in herald patches and fully developed PR eruptions. METHODS: In total, 12 biopsy specimens from 6 patients diagnosed with PR were examined. For each patient, biopsies were taken from both a herald patch and a secondary patch. Specimens were processed for histopathological examination and immunohistochemical staining with a large panel of monoclonal antibodies. RESULTS: Histopathologically, all specimens showed epidermal changes such as parakeratosis, orthokeratosis, epidermal hyperplasia and spongiosis. Less common results included epidermal exocytosis and focal parakeratosis. In all biopsies, the dermal infiltrate of lymphocytes stained positively for monoclonal antibodies specific for T cells. The ratio of the CD4+ (helper) vs. CD8+ (cytotoxic) T cells in the dermal infiltrate was increased in most specimens. Increased staining for Langerhans cells was seen within the dermis of lesional skin. There were no marked differences found in histopathology and immunohistochemistry between the herald patch and secondary lesions. Overall, there was a lack of natural killer cell and B-cell activities in PR lesions. CONCLUSIONS: Our results support a predominantly T-cell mediated immunity in the development of PR.


Assuntos
Imunidade Celular/imunologia , Células de Langerhans/imunologia , Pitiríase Rósea/imunologia , Linfócitos T/imunologia , Adolescente , Adulto , Biópsia , Feminino , Humanos , Células de Langerhans/patologia , Masculino , Pessoa de Meia-Idade , Pitiríase Rósea/patologia , Linfócitos T/patologia , Fatores de Tempo , Adulto Jovem
11.
Eur J Cancer Care (Engl) ; 19(4): 551-3, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19686354

RESUMO

Mesenchymal chondrosarcoma is a rare tumour with orbital involvement being an exceptional occurrence. We present a case of a 22-year old man with such disease, together with details of his management. A brief literature review of this uncommon tumour was also enclosed.


Assuntos
Condrossarcoma Mesenquimal/terapia , Neoplasias Orbitárias/terapia , Neoplasias Ósseas/patologia , Condrossarcoma Mesenquimal/patologia , Terapia Combinada/métodos , Humanos , Masculino , Estadiamento de Neoplasias , Neoplasias Orbitárias/patologia , Resultado do Tratamento , Adulto Jovem
12.
Br J Ophthalmol ; 93(11): 1518-23, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19028743

RESUMO

AIM: To compare the outcome of various surgical approaches of orbital decompression in patients with Graves' orbitopathy (GO) receiving surgery for disfiguring proptosis. METHOD: Data forms and questionnaires from consecutive, euthyroid patients with inactive GO who had undergone orbital decompression for disfiguring proptosis in 11 European centres were analysed. RESULTS: Eighteen different (combinations of) approaches were used, the swinging eyelid approach being the most popular followed by the coronal and transconjunctival approaches. The average proptosis reduction for all decompressions was 5.0 (SD 2.1) mm. After three-wall decompression the proptosis reduction was significantly greater than after two-wall decompression. Additional fat removal resulted in greater proptosis reduction. Complications were rare, the most frequent being worsening of motility, occurring more frequently after coronal decompression. The average change in quality of life (QOL) in the appearance arm of the GO-QOL questionnaire was 20.5 (SD 24.8) points. CONCLUSIONS: In Europe, a wide range of surgical approaches is used to reduce disfiguring proptosis in patients with GO. The extent of proptosis reduction depends on the number of walls removed and whether or not fat is removed. Serious complications are infrequent. Worsening of ocular motility is still a major complication, but was rare in this series after the swinging eyelid approach.


Assuntos
Descompressão Cirúrgica/métodos , Oftalmopatia de Graves/cirurgia , Órbita/cirurgia , Adolescente , Adulto , Idoso , Descompressão Cirúrgica/efeitos adversos , Diplopia/etiologia , Feminino , Oftalmopatia de Graves/fisiopatologia , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Qualidade de Vida , Resultado do Tratamento , Acuidade Visual/fisiologia , Adulto Jovem
13.
Clin Exp Dermatol ; 32(5): 539-40, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17524069

RESUMO

We report the case of a 56-year-old Chinese woman with phaeohyphomycosis. She presented with a 4-year history of a recurring erythematous plague initially diagnosed as chromoblastomycosis on histopathological examination. Surgical excision was performed when the lesion recurred despite intial treatment response to itraconazole. Tissue cultures of the surgical specimen grew Cladophialophora bantiana. Treatment with terbinaffine post surgery was instituted with no recurrence of the lesion to date. Cutaneous phaeohyphomycosis caused by Cladophialophora bantiana is rare and this case highlights the clinical presentation, laboratory findings and treatment of this infection.


Assuntos
Cladosporium/isolamento & purificação , Dermatomicoses/microbiologia , Infecções Oportunistas/microbiologia , Antifúngicos/uso terapêutico , Dermatomicoses/patologia , Dermatomicoses/terapia , Diagnóstico Diferencial , Feminino , Humanos , Hospedeiro Imunocomprometido , Itraconazol/uso terapêutico , Pessoa de Meia-Idade , Naftalenos/uso terapêutico , Infecções Oportunistas/patologia , Infecções Oportunistas/terapia , Terbinafina , Resultado do Tratamento
15.
Br J Dermatol ; 156(3): 480-5, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17300237

RESUMO

BACKGROUND: Sweet's syndrome (SS) is the prototypic neutrophilic dermatosis. First described in 1964, the characterization of new clinical associations, unique histopathological findings and clinical variants have stimulated much interest and discussion recently. However, the prevalence of these unusual variants and clinical associations within a single cohort of patients, has not been described. OBJECTIVES: To describe and evaluate the prevalence of unusual clinical and histopathological features, as well as the clinical associations of SS seen in patients from the National Skin Centre, Singapore. METHODS: This is a retrospective study of all consecutive cases of SS seen at our centre over a 5.5-year period (June 1999-December 2004). Data on associated systemic diseases was obtained from the medical records and matched with information from the National Cancer Registry, Singapore. Patients not actively followed up for more than 3 months were contacted for their updated health status. RESULTS: Thirty-seven patients were identified. Ten (27%) had non-idiopathic SS. These were associated with haematological disorders, connective tissue disorders, infections or a drug. Twenty-nine patients (78%) had at least one atypical clinical or histopathological feature. Atypical clinical features included bullous lesions, SS with hand involvement or neutrophilic dermatoses of the hands and the concomitant existence of subcutaneous SS with pyoderma gangrenosum. SS was the presenting feature in three patients with infections caused by atypical organisms, including Mycobacterium chelonae, Penicillium species and Salmonella type D. Unique histopathological variants included subcutaneous SS and lesions containing an admixture of mature and immature neutrophils. Subcutaneous neutrophilic inflammation seemed to be more common in patients with an underlying haematological disorder. This group of patients also had a lower mean haemoglobin level. CONCLUSIONS: Unusual clinical and histopathological variants of SS described in the literature are similarly encountered in our cohort of patients, with some features being more common than others. We highlight and discuss some unique clinical and histopathological observations seen in our patients with SS.


Assuntos
Síndrome de Sweet/diagnóstico , Adolescente , Adulto , Idoso , Antineoplásicos/efeitos adversos , Benzamidas , Toxidermias/diagnóstico , Toxidermias/patologia , Feminino , Dermatoses da Mão/diagnóstico , Dermatoses da Mão/patologia , Neoplasias Hematológicas/complicações , Humanos , Mesilato de Imatinib , Masculino , Pessoa de Meia-Idade , Neutrófilos/patologia , Piperazinas/efeitos adversos , Pirimidinas/efeitos adversos , Estudos Retrospectivos , Dermatopatias Vesiculobolhosas/diagnóstico , Dermatopatias Vesiculobolhosas/patologia , Síndrome de Sweet/etiologia , Síndrome de Sweet/patologia
16.
Singapore Med J ; 48(1): e22-4, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17245500

RESUMO

Trigeminal trophic syndrome (TTS) is an uncommon condition characterised by anaesthesia, paraesthesias and ala nasi ulceration, following peripheral or central damage to the trigeminal nerve. Only about 100 cases have been described in the literature to date. We report a 74-year-old woman who presented with a right cheek ulcer accompanied by pruritus and paraesthesia for three months. An old right cerebellar infarct was demonstrated on magnetic resonance imaging of the brain. Vertebrobasilar insufficiency leading to the cerebellar infarct is likely to have predisposed her to developing TTS. An underlying infectious, malignant and vasculitic cause for the ulcer was excluded by a skin biopsy. An increased awareness of the predisposing factors and clinical presentations of this important disfiguring condition is necessary to ensure prompt diagnosis and treatment.


Assuntos
Bochecha , Doenças do Nervo Trigêmeo/complicações , Úlcera/etiologia , Idoso , Diagnóstico Diferencial , Evolução Fatal , Feminino , Humanos , Imageamento por Ressonância Magnética , Síndrome , Doenças do Nervo Trigêmeo/diagnóstico , Úlcera/diagnóstico
17.
Clin Otolaryngol ; 31(5): 399-403, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17014449

RESUMO

OBJECTIVE: There has been a lack of patient-centred evidence in the Otolaryngology literature, that non-laser endonasal dacryocystorhinostomy improves the quality of life of patients. Many studies demonstrate successful outcomes based on non-validated subjective patient reporting. The aim of this survey was to evaluate the impact of non-laser endonasal dacryocystorhinostomy on the quality of life of patients using a validated questionnaire, the Glasgow Benefit Inventory (GBI). DESIGN: Prospective non-randomised case series. SETTING: Secondary otorhinolaryngology-ophthalmology centre, single centre. PARTICIPANTS: Sixty-five consecutive patients undergoing non-laser endonasal dacryocystorhinostomy were asked to complete a questionnaire at their follow-up clinic appointment. All patients had a minimum of 9 months follow-up. MAIN OUTCOME MEASURES: A consultant ophthalmologist reviewed each patient six months after surgery and recorded the outcomes as 'cure', 'better', 'no change' or 'worse'. We defined 'success' as cured or better. 'Failure' suggests no improvement or worsening epiphora. The validated 18-item GBI was used. RESULTS: Fully completed questionnaires were received from 55 patients. Mean total GBI scores were +34 for successful non-laser endonasal dacryocystorhinostomy and -19 for failed non-laser endonasal dacryocystorhinostomy (Mann-Whitney z = 3.8, P < 0.001). CONCLUSION: Successful non-laser endonasal dacryocystorhinostomy does confer significant quality of life improvement.


Assuntos
Dacriocistorinostomia , Qualidade de Vida , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Humanos , Terapia a Laser , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Perfil de Impacto da Doença , Inquéritos e Questionários , Resultado do Tratamento , Reino Unido/epidemiologia
19.
Br J Ophthalmol ; 88(9): 1197-200, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15317715

RESUMO

BACKGROUND/AIMS: The management of lower eyelid retraction can be challenging, and established techniques to correct it are not always successful. Previous reports have suggested a role for the ultrathin high density porous polyethylene lower eyelid spacer (Medpor LES) in such patients. The authors report the experience of three surgeons implanting Medpor LES over 1 year, and ascertain whether such implants are a safe and effective alternative to autogenous spacers. METHODS: A prospective, interventional, non-comparative case series of consecutive patients. Surgical indications for Medpor LES were noted. Preoperative and postoperative lower marginal reflex distance (L-MRD), vertical palpebral aperture (PA), lagophthalmos, and scleral show inferior to the limbus (LSS) were recorded, together with major and minor complications. RESULTS: 32 patients (35 eyelids) had a Medpor LES inserted, 22/32 under local anaesthetic, and nine with adjunctive procedures. Mean follow up was 22 months (range 15-28 months). The Medpor LES was effective in reducing the palpebral aperture (p<0.001) and lagophthalmos (p = 0.04) and raising the lower eyelid height by reducing both L-MRD (p = 0.006) and LSS (p<0.001). However there were major complications in 7/32 patients and minor complications in 8/32, most requiring further surgery. Final outcome was good in 24/35 eyelids and satisfactory in 5/35. CONCLUSIONS: Despite a good or satisfactory final outcome in the majority of patients, the value of this technique is limited by complications, and should be reserved for those unsuitable for safer techniques.


Assuntos
Materiais Biocompatíveis/uso terapêutico , Blefaroplastia/métodos , Doenças Palpebrais/cirurgia , Pálpebras/cirurgia , Polietilenos/uso terapêutico , Implantação de Prótese/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Blefaroplastia/efeitos adversos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Resultado do Tratamento
20.
BMJ ; 311(7013): 1131-5, 1995 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-7580708

RESUMO

OBJECTIVE: To evaluate different methods for community based screening for sight threatening diabetic eye disease. DESIGN: Prospective study. SETTING: Mobile screening unit visiting inner city community clinics; hospital assessment clinic (tertiary centre). SUBJECTS: 395 diabetic patients registered with four general practices in an inner city location. INTERVENTIONS: Community based photography with mydriasis and direct ophthalmoscopy through dilated pupils by an experienced ophthalmologist, both compared with reference standard of slit lamp biomicroscopy by a consultant specialist in medical retinal disease. MAIN OUTCOME MEASURES: Sensitivity and specificity of screening method and prevalence of sight threatening diabetic eye disease (moderate preproliferative retinopathy, circinate maculopathy, exudate within 1 disc diameter of fixation, other diabetes related eye disease). RESULTS: 358 subjects underwent photography, 326 attended hospital clinic for ophthalmoscopy, and six were ungradable on photographs and biomicroscopy, leaving 320 for analysis. Of these 295 (91%) attended clinic within four months of photography. Sensitivity of detection of eye disease by photography was 89% (95% confidence interval 80% to 98%), significantly better than for direct ophthalmoscopy (65% (51% to 79%)). Analysis of patients with false negative results indicated possible improvement of photographic sensitivity to 93% by addition of stereoscopic macular pair photographs. Specificity of detection of sight threatening eye disease was 86% (82% to 90%) for photography and 97% (95% to 99%) for direct ophthalmoscopy. CONCLUSIONS: Since high sensitivity is essential for an effective screening programme, a photographic method should be considered as preferred option in national, community based screening programmes. Even in the hands of an experienced ophthalmologist, direct ophthalmoscopy is limited by weaknesses inherent to the instrument.


Assuntos
Oftalmopatias/prevenção & controle , Oftalmoscopia/normas , Fotografação/normas , Seleção Visual/normas , Assistência Ambulatorial/normas , Retinopatia Diabética/prevenção & controle , Inglaterra , Humanos , Prevalência , Estudos Prospectivos , Sensibilidade e Especificidade , Saúde da População Urbana , Seleção Visual/métodos , Acuidade Visual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA